Company: LDDD
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001213900-25-042963
Chunk: 243

Company: Longduoduo Co Ltd
Filing Date: 2025-05-14
Form: 10-Q
Item: Part II, Item 8
Chunk 243
---
 the three months ended March 31, 2025, compared to $634,316 recorded during the
three months ended March 31, 2024. The decrease was primarily attributable to a tactical decision by Management to reduce marketing
expense while we await an economic recovery that will fund an increase in non-essential medical expenditures. Over the longer term, we
intend to continue to devote available resources to expanded advertising and promotion expense for the purpose of achieving a broader
market.

Our net loss for the three months ended March 31, 2025 was $116,320,
compared to a net income of $517,969 for the three months ended March 31, 2024. As noted above, the current economic environment has led
to reduction in patient use of medical services. The government has recently introduced many policies to promote economic recovery. But
it may take some time for the situation to truly improve. Also, the Company intends to improve its operations by adjusting its operational
policies.

Our reporting currency is the U.S. dollar. Our
local currency, the Renminbi (RMB), is our functional currency. Results of operations and cash flow are translated at average exchange
rates during the period being reported upon, and assets and liabilities are translated at the unified exchange rate as quoted by OANDA
on the balance sheet date. Translation adjustments resulting from this process are included in other comprehensive income (loss). For
the three months ended March 31, 2025 and 2024, foreign currency translation adjustments of $13,220 and $(10,118), respectively,
have been reported as other comprehensive income (loss) in the consolidated statement of operations and comprehensive income (loss). 

3

Nine Months Ended March 31, 2025 Compared to Nine Months Ended March
31, 2024

The following table shows key components of the unaudited results of
operations during the nine months ended March 31, 2025 and 2024: 

    For the Nine Months Ended  

    March 31,  

    2025  
    2024  
    Change 

    (Unaudited)  
    (Unaudited)  
    $  
    % 
  
    Total revenue 
    $3,322,287  
    $5,718,060  
    $(2,395,773) 
     (42)%
  
    Cost of revenue